2nd Department of Anesthesiology, Attikon University Hospital
Athens, Attica, 12462, Greece
Location status: Recruiting
NCT Number: NCT04628663
The aim of this study is to examine the effects of intraoperative systemic use of dexmedetomidine on the intraocular pressure (IOP) in patients undergoing spine surgeries in a prone position under general anesthesia.
Interested in participating?
Request Info18 year–90 year
All sexes
Interventional
Not applicable
Athens, Attica, 12462, Greece
Location status: Recruiting
The study is a Prospective, Randomized, Placebo -controlled, Double-Blinded clinical trial Adult patients with an ASA physical status of class I, II or III who are scheduled for an elective spine surgery in prone position under general anesthesia will be included in the study.
The patients will be randomized with closed envelope manner into two groups: the group of dexmedetomidine and the group of normal saline.
In the dexmedetomidine group (DEX group), bolus dose 1,0 μg/kg of dexmedetomidine will be administered in 10min before induction to anesthesia and 0,4-0,8 μg/kg/h of dexmedetomidine will be infused continuously until the end of the surgery.
In the saline group (placebo group), the same volume of saline will be administered in an identical way.
All study medication will be prepared by an independent anesthesiologist who is not associated in the study (who will hold the randomization codes until the end of the study).
All patients will receive the same type of anaesthesia (TIVA with propofol) and postoperative analgesia including paracetamol 1gr iv (4 times/day) and continuous wound infiltration with ropivacaine 0.2% 5ml/h for 48 postoperative hours.
Basic monitoring for the study includes:
ECG, Invasive and noninvasive blood pressure, Heart Rate, EtCO2, SpO2, Cardiac Output (CO), Stroke Volume (SV), Stroke Volume Variation (SVV), Patient State index (PSi), IOP, Urine output.
Measurements
The measurement of IOP will be conducted in both eyes with Icare PRO tonometer by an ophthalmologist who will not know in which group the patient is in the below predefined time points:
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Administration
Other names: Dexmed
Administration
Other names: Saline
Time frame: Up to 15 minutes after the end of operation
The measurement of IOP will be conducted in both eyes with Icare PRO tonometer by an ophthalmologist at predefined time points
Contact information is provided by the study sponsor or research team.
Attikon Hospital
Other
Effects of Systemic Administration of Dexmedetomidine on Intraocular Pressure During Scheduled Spine Surgeries in a Prone Position. Prospective, Randomized, Double-blinded Study.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06275308
Intraocular Pressure
Pittsburgh, Pennsylvania, United States
View Trial DetailsNCT05716945
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Corneal Diseases
Apeldoorn, Gelderland, Netherlands
View Trial DetailsNCT06016712
Delivery, Eye Diseases
Prague, Czechia
View Trial DetailsNCT06522867
Intraocular Pressure
Québec, Quebec, Canada
View Trial Details